| Biedermann, Gregory B |
METIS, NCT02831959: Pivotal, Open-label, Randomized Study of Radiosurgery with or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases from Non-small Cell Lung Cancer (NSCLC). |
|
|
| Completed | 3 | 298 | Europe, Canada, US, RoW | NovoTTF-200M device, Best Standard of Care | NovoCure GmbH | Brain Metastases from Non-small Cell Lung Cancer (NSCLC) | 11/24 | 11/24 | | |
ROADS, NCT04365374: Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile- (Radiation One and Done Study) |
|
|
| Recruiting | 3 | 180 | US | Gamma Tile-Surgically Targeted Radiation Therapy (STaRT), Carrier Tile Brachytherapy Therapy (CTBT), Stereotactic Radiation Therapy | GT Medical Technologies, Inc. | Brain Metastases | 12/25 | 12/27 | | |
| Patel, Toral |
ROADS, NCT04365374: Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile- (Radiation One and Done Study) |
|
|
| Recruiting | 3 | 180 | US | Gamma Tile-Surgically Targeted Radiation Therapy (STaRT), Carrier Tile Brachytherapy Therapy (CTBT), Stereotactic Radiation Therapy | GT Medical Technologies, Inc. | Brain Metastases | 12/25 | 12/27 | | |
SONOBIRD, NCT05902169: Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM |
|
|
| Recruiting | 3 | 560 | Europe, US | SonoCloud-9 (SC9), Carboplatin, CycloButane DiCarboxylic Acid (CBDCA), Lomustine, 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU), Temozolomide, Temodal | CarThera | Glioblastoma, Recurrent Glioblastoma, GBM | 01/28 | 06/28 | | |
ReSPECT-GBM, NCT01906385: Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT) |
|
|
| Recruiting | 1/2 | 55 | US | Rhenium Liposome Treatment, Rhenium-186 NanoLiposome | Plus Therapeutics, National Cancer Institute (NCI) | Glioma | 01/25 | 01/25 | | |
LIBERATE, NCT05383872: Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects with GlioBlastoma Brain Tumors |
|
|
| Recruiting | N/A | 57 | Canada, US | Focused Ultrasound (Exablate Model 4000) | InSightec | Glioblastoma, Glioma, Liquid Biopsy | 12/24 | 03/25 | | |
NCT04427384: Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles) |
|
|
| Recruiting | N/A | 600 | US | GammaTile | GT Medical Technologies, Inc. | Brain Tumor, Recurrent, Brain Tumor, Brain Tumor, Primary, Brain Tumor - Metastatic, Brain Tumor, Adult: Glioblastoma, Brain Tumor, Adult Meningioma | 10/28 | 12/28 | | |
| Paul, Alexandra |
ROADS, NCT04365374: Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile- (Radiation One and Done Study) |
|
|
| Recruiting | 3 | 180 | US | Gamma Tile-Surgically Targeted Radiation Therapy (STaRT), Carrier Tile Brachytherapy Therapy (CTBT), Stereotactic Radiation Therapy | GT Medical Technologies, Inc. | Brain Metastases | 12/25 | 12/27 | | |
EMBOLISE, NCT04402632: Embolization of the Middle Meningeal Artery with ONYX™ Liquid Embolic System for Subacute and Chronic Subdural Hematoma |
|
|
| Active, not recruiting | N/A | 600 | US | Surgical Management, Surgical Management + Treatment, No Treatment, Treatment | Medtronic Neurovascular Clinical Affairs | Subdural Hematoma | 12/24 | 03/25 | | |
WEB PAS, NCT04839705: Post Approval Study - Evaluate the Long-Term Safety and Effectiveness of the WEB Device |
|
|
| Recruiting | N/A | 180 | US | WEB | Microvention-Terumo, Inc. | Wide Neck Bifurcation Intracranial Aneurysms | 12/25 | 12/29 | | |
ARTISSE, NCT02998229: The Artisse™ Intrasaccular Device is Indicated for the Treatment of Wide-neck Bifurcating Intracranial Aneurysms (IAs). |
|
|
| Recruiting | N/A | 220 | US | Artisse™ Intrasaccular Device | Medtronic Neurovascular Clinical Affairs | Intracranial Aneurysm | 02/28 | 02/32 | | |
NCT04427384: Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles) |
|
|
| Recruiting | N/A | 600 | US | GammaTile | GT Medical Technologies, Inc. | Brain Tumor, Recurrent, Brain Tumor, Brain Tumor, Primary, Brain Tumor - Metastatic, Brain Tumor, Adult: Glioblastoma, Brain Tumor, Adult Meningioma | 10/28 | 12/28 | | |
NCT05409989: MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval Study |
|
|
| Recruiting | N/A | 154 | US | FRED™ X™, Flow Re-Direction Endoluminal Device X | Microvention-Terumo, Inc. | Intracranial Aneurysm | 09/29 | 11/29 | | |
| Hanft, Simon |
ROADS, NCT04365374: Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile- (Radiation One and Done Study) |
|
|
| Recruiting | 3 | 180 | US | Gamma Tile-Surgically Targeted Radiation Therapy (STaRT), Carrier Tile Brachytherapy Therapy (CTBT), Stereotactic Radiation Therapy | GT Medical Technologies, Inc. | Brain Metastases | 12/25 | 12/27 | | |
ImmuneSense, NCT04485949: A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma |
|
|
| Active, not recruiting | 2 | 93 | US | IGV-001 Cell Immunotherapy, Placebo, Standard of Care (SOC): Radiation Therapy, SOC: Temozolomide | Imvax | Glioblastoma | 01/25 | 07/27 | | |
NCT04427384: Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles) |
|
|
| Recruiting | N/A | 600 | US | GammaTile | GT Medical Technologies, Inc. | Brain Tumor, Recurrent, Brain Tumor, Brain Tumor, Primary, Brain Tumor - Metastatic, Brain Tumor, Adult: Glioblastoma, Brain Tumor, Adult Meningioma | 10/28 | 12/28 | | |
| Imber, Brandon |
ROADS, NCT04365374: Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile- (Radiation One and Done Study) |
|
|
| Recruiting | 3 | 180 | US | Gamma Tile-Surgically Targeted Radiation Therapy (STaRT), Carrier Tile Brachytherapy Therapy (CTBT), Stereotactic Radiation Therapy | GT Medical Technologies, Inc. | Brain Metastases | 12/25 | 12/27 | | |
NCT04690348: Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study |
|
|
| Recruiting | 2 | 99 | US | Craniotomy, Cesium-131 brachytherapy | Memorial Sloan Kettering Cancer Center, GT Medical Technologies, Inc. | Recurrent Brain Metastases | 12/25 | 12/25 | | |
NCT05079698: A Study of Stereotactic Body Radiotherapy and 177Lu-PSMA-617 for the Treatment of Prostate Cancer |
|
|
| Recruiting | 1 | 27 | US | 177Lu-PSMA-617, Stereotactic Body Radiotherapy (SBRT) | Memorial Sloan Kettering Cancer Center, Novartis Pharmaceuticals | Prostate Cancer | 10/25 | 10/25 | | |
NCT03423628: A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer |
|
|
| Recruiting | 1 | 180 | Europe, Japan, US | Radiation Therapy, Radiotherapy, Radiation treatment, RT, AZD1390, ATM inhibitor | AstraZeneca | Recurrent Glioblastoma Multiforme, Primary Glioblastoma Multiforme, Brain Neoplasms, Malignant, Leptomeningeal Disease (LMD) | 09/26 | 09/26 | | |
|
| Harris, Anita |
ROADS, NCT04365374: Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile- (Radiation One and Done Study) |
|
|
| Recruiting | 3 | 180 | US | Gamma Tile-Surgically Targeted Radiation Therapy (STaRT), Carrier Tile Brachytherapy Therapy (CTBT), Stereotactic Radiation Therapy | GT Medical Technologies, Inc. | Brain Metastases | 12/25 | 12/27 | | |
| Bryant, Karissa |
ROADS, NCT04365374: Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile- (Radiation One and Done Study) |
|
|
| Recruiting | 3 | 180 | US | Gamma Tile-Surgically Targeted Radiation Therapy (STaRT), Carrier Tile Brachytherapy Therapy (CTBT), Stereotactic Radiation Therapy | GT Medical Technologies, Inc. | Brain Metastases | 12/25 | 12/27 | | |
| Patel, Nitesh |
ROADS, NCT04365374: Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile- (Radiation One and Done Study) |
|
|
| Recruiting | 3 | 180 | US | Gamma Tile-Surgically Targeted Radiation Therapy (STaRT), Carrier Tile Brachytherapy Therapy (CTBT), Stereotactic Radiation Therapy | GT Medical Technologies, Inc. | Brain Metastases | 12/25 | 12/27 | | |
